417 related articles for article (PubMed ID: 37444501)
1. Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance.
Lei P; Wang W; Sheldon M; Sun Y; Yao F; Ma L
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444501
[TBL] [Abstract][Full Text] [Related]
2. Glutamine metabolism in breast cancer and possible therapeutic targets.
Li S; Zeng H; Fan J; Wang F; Xu C; Li Y; Tu J; Nephew KP; Long X
Biochem Pharmacol; 2023 Apr; 210():115464. PubMed ID: 36849062
[TBL] [Abstract][Full Text] [Related]
3. Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer.
Iqbal MA; Siddiqui S; Ur Rehman A; Siddiqui FA; Singh P; Kumar B; Saluja D
Mol Oncol; 2021 May; 15(5):1450-1465. PubMed ID: 33400401
[TBL] [Abstract][Full Text] [Related]
4. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
Vaupel P; Schmidberger H; Mayer A
Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
[TBL] [Abstract][Full Text] [Related]
5. Relationship between metabolic reprogramming and drug resistance in breast cancer.
Lv L; Yang S; Zhu Y; Zhai X; Li S; Tao X; Dong D
Front Oncol; 2022; 12():942064. PubMed ID: 36059650
[TBL] [Abstract][Full Text] [Related]
6. Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer.
Shum HCE; Wu K; Vadgama J; Wu Y
J Pers Med; 2023 Jan; 13(1):. PubMed ID: 36675817
[TBL] [Abstract][Full Text] [Related]
7. Perspectives of Reprogramming Breast Cancer Metabolism.
Wang YP; Lei QY
Adv Exp Med Biol; 2017; 1026():217-232. PubMed ID: 29282686
[TBL] [Abstract][Full Text] [Related]
8. Glucose Metabolism and Glucose Transporters in Breast Cancer.
Shin E; Koo JS
Front Cell Dev Biol; 2021; 9():728759. PubMed ID: 34552932
[TBL] [Abstract][Full Text] [Related]
9. Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib
Lorito N; Bacci M; Smiriglia A; Mannelli M; Parri M; Comito G; Ippolito L; Giannoni E; Bonechi M; Benelli M; Migliaccio I; Malorni L; Chiarugi P; Morandi A
Cells; 2020 Mar; 9(3):. PubMed ID: 32164162
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma.
An F; Chang W; Song J; Zhang J; Li Z; Gao P; Wang Y; Xiao Z; Yan C
J Bone Oncol; 2024 Feb; 44():100521. PubMed ID: 38288377
[TBL] [Abstract][Full Text] [Related]
11. Exosome-mediated metabolic reprogramming: Implications in esophageal carcinoma progression and tumor microenvironment remodeling.
Xi Y; Shen Y; Chen L; Tan L; Shen W; Niu X
Cytokine Growth Factor Rev; 2023 Oct; 73():78-92. PubMed ID: 37696716
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the Warburg effect and progression of triple-negative breast cancer.
Liu S; Li Y; Yuan M; Song Q; Liu M
Front Oncol; 2022; 12():1060495. PubMed ID: 36776368
[TBL] [Abstract][Full Text] [Related]
13. Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review.
Liu Y; Zhang Z; Wang J; Chen C; Tang X; Zhu J; Liu J
Onco Targets Ther; 2019; 12():1195-1204. PubMed ID: 30863087
[TBL] [Abstract][Full Text] [Related]
14. The role of metabolic reprogramming in cancer metastasis and potential mechanism of traditional Chinese medicine intervention.
Wang D; Wang F; Kong X; Li Q; Shi H; Zhao S; Li W; Li Y; Meng J
Biomed Pharmacother; 2022 Sep; 153():113376. PubMed ID: 36076519
[TBL] [Abstract][Full Text] [Related]
15. Recent Metabolomics Analysis in Tumor Metabolism Reprogramming.
Han J; Li Q; Chen Y; Yang Y
Front Mol Biosci; 2021; 8():763902. PubMed ID: 34901157
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
Tyszka-Czochara M; Konieczny P; Majka M
J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
[TBL] [Abstract][Full Text] [Related]
17. Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.
Oliveras-Ferraros C; Vazquez-Martin A; Cuyàs E; Corominas-Faja B; Rodríguez-Gallego E; Fernández-Arroyo S; Martin-Castillo B; Joven J; Menendez JA
Cell Cycle; 2014; 13(7):1132-44. PubMed ID: 24553122
[TBL] [Abstract][Full Text] [Related]
18. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
Seo J; Yun JE; Kim SJ; Chun YS
Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
[TBL] [Abstract][Full Text] [Related]
19. Low Glucose-Induced Overexpression of HOXC-AS3 Promotes Metabolic Reprogramming of Breast Cancer.
Zhu W; Chen X; Guo X; Liu H; Ma R; Wang Y; Liang Y; Sun Y; Wang M; Zhao R; Gao P
Cancer Res; 2022 Mar; 82(5):805-818. PubMed ID: 35031573
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer.
Hussein S; Khanna P; Yunus N; Gatza ML
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
